We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$178B
1-Year Est. Return
37.23%
This Fund
S&P 500
This Quarter
Est. Return
-12.49%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$87.8B
AUM Growth
-$12.2B
(-12%)
Cap. Flow
-$2.48B
Cap. Flow
% of AUM
-2.83%
Top 10 Holdings %
Top 10 Hldgs %
9.65%
Holding
2,799
New
83
Increased
1,214
Reduced
1,273
Closed
107
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$251M |
| 2 |
Allstate
ALL
|
+$213M |
| 3 |
Old Republic International
ORI
|
+$135M |
| 4 |
Ross Stores
ROST
|
+$120M |
| 5 |
MKS Inc
MKSI
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Valero Energy
VLO
|
+$406M |
| 2 |
Hershey
HSY
|
+$363M |
| 3 |
CTRA
Coterra Energy
CTRA
|
+$191M |
| 4 |
Westlake Corp
WLK
|
+$146M |
| 5 |
Devon Energy
DVN
|
+$143M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.44% |
| 2 | Industrials | 13.67% |
| 3 | Financials | 13.5% |
| 4 | Healthcare | 10.72% |
| 5 | Consumer Discretionary | 10% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
First Horizon
FHN
$12.1B
| $3.04M | ﹤0.01% |
139,199
+17,735
| +15% | +$399K |
|
1327
Globus Medical
GMED
$11.2B
| $3.04M | ﹤0.01% |
54,173
+803
| +2% | +$52.8K |
|
|
BCPC
1328
Balchem Corp
BCPC
$5.72B
| $3.04M | ﹤0.01% |
23,444
+16,672
| +246% | +$2.09M |
|
1329
AXIS Capital
AXS
$7.55B
| $3.04M | ﹤0.01% |
53,270
+7,767
| +17% | +$443K |
|
1330
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.81B
| $3.04M | ﹤0.01% |
+37,455
| New | +$3.16M |
|
|
EFOR
1331
Everforth Inc
EFOR
$1.32B
| $3.04M | ﹤0.01% |
33,643
-24,722
| -42% | -$2.54M |
|
1332
Rocket Companies
RKT
$38.9B
| $3.01M | ﹤0.01% |
409,289
+8,404
| +2% | +$72.6K |
|
1333
Corcept Therapeutics
CORT
$12B
| $3.01M | ﹤0.01% |
126,488
-5,582
| -4% | -$122K |
|
1334
Erie Indemnity
ERIE
$13.2B
| $2.99M | ﹤0.01% |
15,547
+7,259
| +88% | +$1.26M |
|
1335
Vanda Pharmaceuticals
VNDA
$302M
| $2.99M | ﹤0.01% |
273,915
+15,334
| +6% | +$159K |
|
1336
Cytokinetics
CYTK
$10.4B
| $2.98M | ﹤0.01% |
75,949
+52,886
| +229% | +$2.13M |
|
1337
Astrana Health
ASTH
$1.77B
| $2.97M | ﹤0.01% |
76,903
+58,028
| +307% | +$2.21M |
|
1338
Service Corp International
SCI
$11.6B
| $2.95M | ﹤0.01% |
42,681
-675
| -2% | -$46.2K |
|
1339
Eldorado Gold
EGO
$9.89B
| $2.93M | ﹤0.01% |
459,095
-181,744
| -28% | -$1.65M |
|
1340
Climb Global Solutions
CLMB
$519M
| $2.93M | ﹤0.01% |
352,796
| – | – |
|
1341
Palomar
PLMR
$3.45B
| $2.93M | ﹤0.01% |
45,493
-1,460
| -3% | -$88.1K |
|
1342
BioLife Solutions
BLFS
$1.7B
| $2.93M | ﹤0.01% |
212,045
-30,653
| -13% | -$450K |
|
1343
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $2.92M | ﹤0.01% |
70,072
| – | – |
|
1344
Preformed Line Products
PLPC
$2.28B
| $2.9M | ﹤0.01% |
47,140
+703
| +2% | +$43.4K |
|
1345
Roblox
RBLX
$27B
| $2.87M | ﹤0.01% |
87,412
+566
| +0.7% | +$19K |
|
1346
Digi International
DGII
$3.1B
| $2.85M | ﹤0.01% |
117,862
-12,700
| -10% | -$275K |
|
1347
ICU Medical
ICUI
$4.61B
| $2.84M | ﹤0.01% |
17,279
+597
| +4% | +$115K |
|
|
LAND
1348
Gladstone Land Corp
LAND
$360M
| $2.81M | ﹤0.01% |
126,890
+20,792
| +20% | +$628K |
|
1349
Mesa Laboratories
MLAB
$574M
| $2.81M | ﹤0.01% |
13,771
-1,722
| -11% | -$377K |
|
1350
Willdan Group
WLDN
$1.3B
| $2.79M | ﹤0.01% |
101,202
-1,857
| -2% | -$50.8K |
|
Similar funds
VGA
Victory Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Victory Capital Management held 2,799 positions worth $87.8B, down 12% from $100B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Victory Capital Management's Q2 2022 filing shows 83 new, 1,214 increased, 1,273 reduced and 107 closed positions. Its largest new stake was argenx: 81,325 shares worth $30.8M. The largest sale was Valero Energy, an estimated $406M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Financials.
- Victory Capital Management's largest Q2 2022 buy was argenx: 81,325 shares worth $30.8M.
- Victory Capital Management added most to Hologic in Q2 2022, an estimated $251M increase.
- Victory Capital Management's biggest Q2 2022 reduction was Valero Energy, cutting an estimated $406M.
- Victory Capital Management fully exited Dominion Energy, Inc. 2019 Series A Corporate Units in Q2 2022, selling an estimated $79.1M.
- Victory Capital Management's ten largest holdings make up 9.6% of its $87.8B portfolio in Q2 2022.
- Victory Capital Management opened 83 new positions and closed 107 in Q2 2022.
- Victory Capital Management's portfolio value fell 12% quarter-over-quarter to $87.8B.
Based on Victory Capital Management's 13F filing for Q2 2022, filed 1 Aug 2022.